Showing results (191-200 of 216) with videos related to
Sort By:
Pageof 22
Rheumatology (Oxford, England)|October 27, 1999
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapyG Filaci, M Cutolo, M Scudeletti, et al.Journal of Endocrinological Investigation|May 26, 2020
Body composition and bone status in relation to microvascular damage in systemic sclerosis patientsS Paolino, E Gotelli, F Goegan, et al.Annals of the Rheumatic Diseases|January 14, 2005
Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparisonM Cutolo, G J M Maestroni, K Otsa, et al.Rheumatology (Oxford, England)|January 4, 2021
Patients' and rheumatologists' perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis-an international survey within the GLORIA studyT Santiago, M Voshaar, M de Wit, et al.Clinical and Experimental Rheumatology|February 10, 2006
Localized and systemic forms of scleroderma in adults and children F Atzeni, A Bardoni, M Cutolo, et al.Reumatismo|January 9, 2014
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritisM Todoerti, W Maglione, E Bernero, et al.Annals of the Rheumatic Diseases|July 16, 2002
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatologyF Buttgereit, J A P da Silva, M Boers, et al.The Journal of Rheumatology|October 24, 2001
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritisC Salvarani, P Macchioni, I Olivieri, et al.Seminars in Arthritis and Rheumatism|November 6, 2022
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trialL Hartman, M El Alili, M Cutolo, et al.Annals of the Rheumatic Diseases|August 19, 2005
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial dataJ A P Da Silva, J W G Jacobs, J R Kirwan, et al.Pageof 22